Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues

PLoS One. 2015 May 26;10(5):e0127109. doi: 10.1371/journal.pone.0127109. eCollection 2015.

Abstract

MicroRNA-21 (miR-21) is recognized as an oncomir and shows up-regulation in many types of human malignancy. The aim of this study was to investigate the association of miR-21 expression associated with HPV infection in normal and abnormal cervical tissues. Cervical tissue samples with different cytological or histopathological grades were investigated for HPV by PCR and for miR-21 and programmed cell death, protein 4 (PDCD4) expression using quantitative real-time PCR (qRT-PCR). Laser capture microdissection (LCM) of stromal and epithelial tissues and in situ hybridization (ISH) using locked nucleic acid (LNA) probes were performed on a subset of fixed specimens. Cell line experiments were conducted on fibroblasts stimulated in culture media from HeLa cells, which were then assessed for miR-21, PDCD4, IL-6 and α-SMA expression by qRT-PCR. Twenty normal cervical cell, 12 cervicitis, 14 cervical intraepithelial neoplastic I (CIN I), 22 CIN II-III and 43 cervical squamous cell carcinoma (SCC) specimens were investigated. miR-21 levels were significantly lower in normal than in abnormal tissues. The expression of miR-21 in HPV negative normal cytology was significantly lower than in HPV positive samples in abnormal tissue and SCC. The miR-21 expression was significantly higher in HPV negative cervicitis than HPV negative normal cells. LCM and ISH data showed that miR-21 is primarily expressed in the tumor-associated stromal cell microenvironment. Fibroblasts treated with HeLa cell culture media showed up-regulated expression of miR-21, which correlated with increased expression of α-SMA and IL-6 and with down-regulation of PDCD4. These results demonstrate that miR-21 is associated with HPV infection and involved in cervical lesions as well as cervicitis and its up-regulation in tumor-stroma might be involved in the inflammation process and cervical cancer progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / genetics
  • Apoptosis Regulatory Proteins / genetics
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / virology
  • Cell Line, Tumor
  • Cervix Uteri / pathology
  • Cervix Uteri / virology*
  • Down-Regulation / genetics
  • Female
  • Fibroblasts / pathology
  • Fibroblasts / virology
  • HeLa Cells
  • Humans
  • Interleukin-6 / genetics
  • MicroRNAs / genetics*
  • Papillomaviridae / pathogenicity
  • Papillomavirus Infections / genetics*
  • Papillomavirus Infections / pathology
  • Papillomavirus Infections / virology*
  • RNA-Binding Proteins / genetics
  • Up-Regulation / genetics*
  • Uterine Cervical Dysplasia / genetics
  • Uterine Cervical Dysplasia / pathology
  • Uterine Cervical Dysplasia / virology
  • Uterine Cervical Neoplasms / genetics
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / virology
  • Uterine Cervicitis / genetics*
  • Uterine Cervicitis / pathology
  • Uterine Cervicitis / virology*

Substances

  • ACTA2 protein, human
  • Actins
  • Apoptosis Regulatory Proteins
  • Interleukin-6
  • MIRN21 microRNA, human
  • MicroRNAs
  • PDCD4 protein, human
  • RNA-Binding Proteins

Grants and funding

Financial support was from the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0212/2550) to student S.B. and advisor C.P. The research was supported by Faculty of Medicine, Khon Kaen University (Grant No. I54225 and I57210); Khon Kaen University, Thailand (Grant No. 551601, 564101 and 573001) and Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.